Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP785350.RAjcrbI4SGSa7VXUGW_gCBta7sy26Su0qu40poKaWrIB4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP785350.RAjcrbI4SGSa7VXUGW_gCBta7sy26Su0qu40poKaWrIB4130_assertion type Assertion NP785350.RAjcrbI4SGSa7VXUGW_gCBta7sy26Su0qu40poKaWrIB4130_head.
- NP785350.RAjcrbI4SGSa7VXUGW_gCBta7sy26Su0qu40poKaWrIB4130_assertion description "[The novel compounds presented here were tested for CXCR4 affinity, toxicity, receptor activation, and for their ability to prevent breast cancer metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785350.RAjcrbI4SGSa7VXUGW_gCBta7sy26Su0qu40poKaWrIB4130_provenance.
- NP785350.RAjcrbI4SGSa7VXUGW_gCBta7sy26Su0qu40poKaWrIB4130_assertion evidence source_evidence_literature NP785350.RAjcrbI4SGSa7VXUGW_gCBta7sy26Su0qu40poKaWrIB4130_provenance.
- NP785350.RAjcrbI4SGSa7VXUGW_gCBta7sy26Su0qu40poKaWrIB4130_assertion SIO_000772 24045366 NP785350.RAjcrbI4SGSa7VXUGW_gCBta7sy26Su0qu40poKaWrIB4130_provenance.
- NP785350.RAjcrbI4SGSa7VXUGW_gCBta7sy26Su0qu40poKaWrIB4130_assertion wasDerivedFrom befree-20150227 NP785350.RAjcrbI4SGSa7VXUGW_gCBta7sy26Su0qu40poKaWrIB4130_provenance.
- NP785350.RAjcrbI4SGSa7VXUGW_gCBta7sy26Su0qu40poKaWrIB4130_assertion wasGeneratedBy ECO_0000203 NP785350.RAjcrbI4SGSa7VXUGW_gCBta7sy26Su0qu40poKaWrIB4130_provenance.